Emily Singer commissions and edits scientist-written content and develops new resources for the community. She joined The Transmitter in 2023 and has previously held a variety of editorial roles at the Simons Foundation, including editor for neuroscience collaborations, and senior biology writer and contributing editor at Quanta Magazine. Before joining the foundation, she was biomedical editor at Technology Review.
Emily Singer
Chief opinion editor
The Transmitter
From this contributor
Amid funding uncertainty, neuroscientists report a mix of cynicism, persistence
By
Emily Singer
28 August 2026 | 5 min read
How insights from network theory can boost interdisciplinary efforts
By
Emily Singer
23 February 2026 | 0 min watch
Education
- Certificate in science communication, University of California, Santa Cruz
- B.A. in biology, University of California, Santa Cruz
Fellowships
- AAAS Mass Media Fellowship
Explore more from The Transmitter
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
By
Amber Dance
18 September 2026 | 9 min read
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
By
Brendan Borrell
17 September 2026 | 4 min read
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
By
Brady Huggett
17 September 2026 | 1 min read